XBiotech (XBIT) Return on Capital Employed [ROCE] (2015 - 2026)
XBiotech's Return on Capital Employed [ROCE] was -34.86% in Q2 2026, down 14.15 percentage points from -20.71% a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at XBiotech came in at -33.41%, down 11.94 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now declined for five consecutive years, with a five-year change of -30.27 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -21.48% in FY2024 (-5.19 pp), -16.29% in FY2023 (-2.85 pp), -13.44% in FY2022 (-5.38 pp) and -8.06% in FY2021 (-4.92 pp).
- Quarterly Return on Capital Employed [ROCE] has moved between -36.32% (Q4 2025) and -7.29% (Q3 2021) over five years.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in two of the last seven quarters, with an average year-over-year change of -5.99 percentage points.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2025 (a gain of 1.34 percentage points); the worst was Q2 2026 (a drop of 14.15 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 43.74% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.33% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 11.32% |
| 10 | XBiotech | 58.23 Mn | -439.75 Mn | - | -36.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -34.86% |
| Dec 31, 2025 | -36.32% |
| Sep 30, 2025 | -20.16% |
| Jun 30, 2025 | -20.71% |
| Mar 31, 2025 | -24.41% |
| Dec 31, 2024 | -22.43% |
| Sep 30, 2024 | -21.51% |
| Jun 30, 2024 | -20.98% |
| Mar 31, 2024 | -19.60% |
| Dec 31, 2023 | -16.90% |
| Sep 30, 2023 | -16.33% |
| Jun 30, 2023 | -14.93% |
| Mar 31, 2023 | -14.05% |
| Dec 31, 2022 | -14.11% |
| Sep 30, 2022 | -13.14% |
| Jun 30, 2022 | -11.85% |
| Mar 31, 2022 | -10.88% |
| Dec 31, 2021 | -9.16% |
| Sep 30, 2021 | -7.29% |
| Jun 30, 2021 | -6.77% |
API Access
XBiotech Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();